Kirk Clark
Novartis (United States)(US)
Publications by Year
Research Areas
Protease and Inhibitor Mechanisms, Peptidase Inhibition and Analysis, Computational Drug Discovery Methods, Genomics and Chromatin Dynamics, RNA Interference and Gene Delivery
Most-Cited Works
- → Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5(1993)1,282 cited
- → A putative modular domain present in diverse signaling proteins(1993)444 cited
- → Identification of Dipeptidyl Nitriles as Potent and Selective Inhibitors of Cathepsin B through Structure-Based Drug Design(2001)136 cited
- → Characterization of human PLD2 and the analysis of PLD isoform splice variants(1998)122 cited
- → Synthesis of a well-defined glycoconjugate vaccine by a tyrosine-selective conjugation strategy(2013)119 cited
- → N-Alkyl Urea Hydroxamic Acids as a New Class of Peptide Deformylase Inhibitors with Antibacterial Activity(2002)108 cited
- → Outcome of the First wwPDB/CCDC/D3R Ligand Validation Workshop(2016)67 cited
- → Histone-like transcription factors in eukaryotes(1997)66 cited
- → Discovery of Potent, Selective, and Orally Active Carboxylic Acid Based Inhibitors of Matrix Metalloproteinase-13(2009)56 cited
- → Preclinical target validation using patient-derived cells(2015)53 cited